Amarantus To Present Poster on Alzheimer’s Blood Assay At 12th International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders

Amarantus To Present Poster on Alzheimer’s Blood Assay At 12th International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders
Amarantus, a biotechnology company developing diagnostics in neurology and orphan drugs in neurology, ophthalmology, psychiatry and regenerative medicine, recently announced their abstract “The LymPro® Assay: A Biomarker For Alzheimer’s Disease Using Blood Samples From Clinically Diagnosed Alzheimer’s Disease And Cognitively Intact Subjects” has been accepted for poster presentation at the 12th International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders. The conference will be held

Knowledge is power when living with alzheimers.

Get access to the web’s leading Alzheimer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *